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Introduction
Methods
Peripheral blood mononuclear cells were collected from 8 well-characterized
HIV-1+ males on ART with varied lengths of active infection. Resting CD4 T cells
were plated at multiple dilutions in replicate and maximally stimulated to induce
latent viruses to grow in the supernatants. Cultures were screened for the
presence of virus antigen and those that were positive were collected for
analysis. ln order to genetically define each person’s viral reservoir, the HIV-1
envelope gene (env) was amplified and sequenced from each culture by single
genome sequencing (SGS). At least 3 sequences were obtained from each culture
well and 3-5 wells were sequenced from each individual. All sequences from an
individual were aligned and used to generate a maximum-likelihood tree. If we
confirmed a single virus was contained in the well, all well sequences were then
used to generate a well consensus sequence, which were aligned to produce a
maximum-likelihood tree. Finally, cultures confirmed by sequencing to contain
single viruses were then titered and measured for sensitivity to bNAbs in the
standard HIV-1 TZM-bl neutralization assay.
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• SGS revealed differences in reservoir diversity between participants, with some
individuals harboring unique viruses while others harbor a few clonal strains.
• Our data suggests that average pairwise distance (APD) is associated with greater
resistance to bNAbs; however, individuals who start ART early in infection and
develop limited virus variation are more likely to be sensitive to bNAb treatment.
Figure 1: Amplifying env genes
Antiretroviral therapy (ART) can successfully suppress HIV-1 replication, however,
patients on ART must maintain consistent therapy in order to avoid rebound from
a latent viral reservoir. Strategies are urgently needed to clear or limit this
reservoir. Individuals infected for longer periods with replicating virus prior to ART
harbor greater viral genetic diversity in their reservoir. Broadly neutralizing
antibodies (bNAbs) have been identified and are capable of neutralizing highly
diverse viruses. More studies are needed to explore the role viral diversity plays in
the potential efficacy of treatment with bNAbs. To do so, we have characterized
HIV-1 genetic diversity in individuals with varying lengths of infection, as well as
the sensitivity of their inducible virus reservoir to bNAbs.










Maximum likelihood tree of gapstripped amino acid
consensuses from each outgrowth virus based on trees
from Figure 2. Wells containing multiple viruses were
excluded from the tree. Participant OM5346 was co-
infected with subtypes B and AG viruses. For individuals
with higher levels of viral diversity, no wells had identical
viruses and branched separately; however, low-diversity
individuals harbored essentially 1-2 different viruses.
APD vs bNAb geomean IC50
(multiply-infected individual removed)
(A) Average pairwise distance (APD) was calculated as a measure of reservoir diversity
for each participant in the study using DIVEIN (Deng et al., Biotechniques, 2010).
(B) Each virus was tested for neutralization sensitivity against a panel of 10 HIV-1
bNAbs: CD4bs targeting antibodies VRC01, VRC07-523, 3BNC117, and N6, V1V2
targeting antibodies PGDM1400, CAP256.VRC26.25, and PG09, V3 targeting antibodies
PGT121 and 10-1074, and MPER targeting antibody 10E8. Geometric mean IC50s were
calculated against this panel as a measure of overall bNAb sensitivity for each
participant. Spearman’s correlations were performed to determine the relationship
between APD and bNAb sensitivity. Interestingly, while these factors are not statistically
significant in our data set, there is a trend towards greater resistance to bNAbs in
individuals who have greater diversity. APD could not be calculated for participant
OM5148 due to QVOA wells containing multiple viruses as determined by SGS.


















(A) Structure of the HIV-1 genome. (B) Viral RNA was extracted from each wells’
supernatants to produce cDNA, using reverse genetics. The HIV-1 envelope gene
(env) was amplified using SGS and Sanger sequencing from these reservoir-
derived outgrowth viruses.
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Figure 2: Viral Reservoir Diversity using Maximum Likelihood Trees 
Maximum likelihood trees for each participants’ sequencing. Trees are rooted at midpoint
for visualization. Each dot represents a single sequence and is colored based on the well it
originated from. Bootstraps over 90% are indicated. Trees revealed 80% of wells harbored
a single virus. Despite utilizing a very small sample size in the analysis, we observed a
clear trend toward lower diversity in individuals with short active infections.
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Figure 3: Maximum likelihood tree of participant reservoir virusesTable 1: Clinical Characteristics of Study Participants
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